---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-096176"
form_type: "8-K"
ticker: "ALNY"
cik: "0001178670"
company_name: "ALNYLAM PHARMACEUTICALS, INC."
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:20:19.224467+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Steven Paul, M.D. to retire from Alnylam Board effective April 16, 2022

## Summary
- Steven Paul resigns from Board effective April 16, 2022; no disagreement with company operations.
- Board size reduced from 11 to 10 members upon Dr. Paul's departure.
- Colleen F. Reitan joins PC&C Committee; Amy W. Schulman remains Chair.
- Dr. Paul served on Alnylam Board since September 2010; praised for decade of service.

## SEC filing metadata
- accession: 0001193125-22-096176
- form_type: 8-K
- ticker: ALNY
- cik: 0001178670
- company_name: ALNYLAM PHARMACEUTICALS, INC.
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/0001193125-22-096176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/d343633d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-096176
- JSON: https://secwatch.observer/filing/0001193125-22-096176.json
- Plain text: https://secwatch.observer/filing/0001193125-22-096176.txt

## Key facts
- Executive change
  Steven M. Paul resigned as Director at ALNYLAM PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: On March 31, 2022, Steven M. Paul, M.D. informed the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) of his resignation from the Board effective as of April 16, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/0001193125-22-096176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.